bioTheranostics, Inc. - Medical Equipment - Deals and Alliances Profile

Date: October 20, 2014
Pages: 29
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: B2667DB6F67EN
Leaflet:

Download PDF Leaflet

bioTheranostics, Inc. - Medical Equipment - Deals and Alliances Profile
Summary

bioTheranostics, Inc. (bioTheranostics), formerly AviaraDx, Inc., is a molecular diagnostics company. It undertakes discovery, development and commercialization of molecular-based diagnostic, prognostic and predictive tests for the treatment of cancer. The company’s product portfolio includes CancerTYPE ID, Breast Cancer Index, CancerTARGET ID, CancerTREATMENT ID, and bioT3. It operates as a CLIA-certified, CAP-accredited diagnostic laboratory. bioTheranostics has partnerships with clinical and academic leaders in cancer diagnostics such as Harvard Medical School, Baylor College of Medicine, Mayo Clinic, MD Anderson Cancer Center, Sharp Hospital, Jules Bordet Institute, Sarah Cannon Research Institute and others. It is a subsidiary of bioMerieux S.A. bioTheranostics is headquartered in San Diego, California, the US.

bioTheranostics, Inc. - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements: The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy: The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company: Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.: The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company: Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research: Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
bioTheranostics, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014
bioTheranostics, Inc., Medical Equipment Deals By Type, 2008 to YTD 2014
bioTheranostics, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014
bioTheranostics, Inc., Medical Equipment, Deals By Market, 2008 to YTD 2014
bioTheranostics, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014
bioTheranostics, Inc., Medical Equipment, Deal Details
Venture Financing
AviaraDx Raises US$8 Million In Series A Financing
Partnerships
Ferrer inCode Enters Into An Agreement With bioTheranostics
bioTheranostics Signs An Agreement With Lab21
Acquisition
bioMerieux Acquires AviaraDx
bioTheranostics, Inc. - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Recent Developments
Corporate Communications
Oct 06, 2014: bioTheranostics Appoints Nicolas Barthelemy As President And CEO
Jul 23, 2014: bioTheranostics Names Ramesh Hariharan as Vice President of Marketing
Aug 27, 2013: bioTheranostics Appoints Three Key Executives
Mar 19, 2013: bioTheranostics Appoints Michael C Dugan As CMO
Product News
Apr 02, 2014: bioTheranostics Announces Contract with Three Rivers Provider Network for coverage of Breast Cancer Index
Apr 02, 2014: bioTheranostics Announces Contract with Three Rivers Provider Network for coverage of CancerTYPE ID
Mar 12, 2014: Tennessee Oncology First in Tennessee to Use Test to Determine Risk of Both Early and Late Breast Cancer Recurrence and Likelihood of Benefit from Extended Endocrine Therapy
Oct 29, 2013: bioTheranostics Signs Collaboration Agreement with Top U.S. Hospital and Reference Laboratory to Offer CancerTYPE ID Molecular Test for Metastatic Cancer
Sep 12, 2013: bioTheranostics’ Breast Cancer IndexSM Molecular Test Identifies Risk for Early and Late Breast Cancer Recurrence, Lancet Oncology Study Finds
Aug 22, 2013: bioTheranostics Receives Positive Coverage Decision and In-Network Provider Status from Tufts Health Plan for Its CancerTYPE ID Molecular Test for Metastatic Cancer
Jul 10, 2013: Studies Show bioTheranostics’ Breast Cancer Index Identifies Breast Cancer Patients at Risk for Early and Late Recurrence, and Predicts Benefit from Extended Endocrine Therapy
May 31, 2013: Studies Further Demonstrate Clinical Utility & Cost-Effectiveness of bioTheranostics’ CancerTYPE ID Molecular Test in Metastatic Cancer
May 29, 2013: bioTheranostics To Present Data On CancerTYPE ID And Breast Cancer Index At 2013 ASCO Annual Meeting
May 02, 2013: bioTheranostics’s Prostate Cancer Index Predicts Risk For Prostate Cancer Recurrence, Study Finds
Mar 26, 2013: bioTheranostics’ CancerTYPE ID More Accurate Than Immunohistochemistry In Diagnosing Metastatic Tumors, Study Finds
Clinical Trials
Sep 12, 2013: bioTheranostics’ Breast Cancer IndexSM Molecular Test Identifies Risk for Early and Late Breast Cancer Recurrence, Lancet Oncology Study Finds
Jul 10, 2013: Studies Show bioTheranostics’ Breast Cancer Index Identifies Breast Cancer Patients at Risk for Early and Late Recurrence, and Predicts Benefit from Extended Endocrine Therapy
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

bioTheranostics, Inc., Medical Equipment, Key Facts
bioTheranostics, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014
bioTheranostics, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014
bioTheranostics, Inc., Medical Equipment Deals By Type, 2008 to YTD 2014
bioTheranostics, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014
bioTheranostics, Inc., Deals By Market, 2008 to YTD 2014
bioTheranostics, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014
AviaraDx Raises US$8 Million In Series A Financing
Ferrer inCode Enters Into An Agreement With bioTheranostics
bioTheranostics Signs An Agreement With Lab21
bioMerieux Acquires AviaraDx
bioTheranostics, Inc., Key Competitors
bioTheranostics, Inc., Key Employees

LIST OF FIGURES

bioTheranostics, Inc., Medical Equipment, Deals by Type, 2008 to YTD 2014
bioTheranostics, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014
bioTheranostics, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014
bioTheranostics, Inc., Medical Equipment, Deals By Market, 2008 to YTD 2014
bioTheranostics, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014
bioTheranostics, Inc., Medical Equipment, Deals by Type, 2008 to YTD 2014
bioTheranostics, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014
bioTheranostics, Inc., Medical Equipment, Deals by Market, 2008 to YTD 2014
Skip to top


Ask Your Question

bioTheranostics, Inc. - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: